Worth a closer look
- Open-market purchase with their own money (Form 4 code P), not a grant or option exercise.
- Their past buys: 4 of 7 beat the S&P 500 over 90 days.
Reasons for caution
- Similar past buys beat the S&P 500 only 46% of the time (110 cases); the typical one trailed it by 3.5%.
What happened after this filing
Insider Twins: past buys with the same traits
2 insiders buying · no CEO or CFO · $250K–$1M · stock down 20%+ in 3 months
AVTR May 11, 2026 +65.6% vs S&PFIX May 14, 2020 +65.5% vs S&PMSTR May 13, 2022 +59.7% vs S&PATXI Sep 12, 2023 -86.8% vs S&PDNA May 16, 2024 -74.3% vs S&PCDZI Dec 17, 2021 -55.9% vs S&PWhat we couldn't check
- Why they traded. Filings don't say, and we don't guess.
- Company news after the filing, and any private terms.
Matt McGraner (an officer) bought $199K of NXRT at about $16.62 between Nov 5, 2026 and Nov 6, 2026, reported to the SEC on Nov 9, 2026. Buys like this beat the S&P 500 46% of the time since 2020, against 46% for all insider buys. We found 2 points that make it worth a closer look and 1 reason for caution. History, not a prediction.
Following. We'll keep this page updated; see everything you follow. Want an email when the 30 and 90-day results land? Use the NXRT alerts below.
Get this week's insider report
The week's biggest insider buys, every new cluster buy and the stocks to watch, in one printable PDF. Plus the free Monday email.
Check your inbox to confirm, so you get next week's report too.
Written by fixed rules from SEC filings and our measured history, not by an AI model. Public data only. History, not a prediction, and not investment advice.